Venrock Adviser, LLC

Position in DYN — Dyne Therapeutics, Inc.

CIK 1615982 NEW YORK, NY

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$39,413,042

-$3,108,696 QoQ

Shares Held

2,173,913

0.0% QoQ

Ownership

1.52%

of shares outstanding

% of Portfolio

1.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Venrock Adviser, LLC holds $2,679,121,844 across 33 Biotechnology names. DYN ranks #18 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	8,493,321	$714,882,828
2	ERAS	Erasca, Inc.	16,382,812	$265,073,898
3	ORKA	Oruka Therapeutics, Inc.	4,148,428	$203,480,393
4	SYRE	Spyre Therapeutics, Inc.	3,685,448	$185,893,997
5	KALV	KalVista Pharmaceuticals, Inc.	6,474,485	$130,331,383
6	DNTH	Dianthus Therapeutics, Inc. /DE/	1,180,000	$99,025,600
7	DMRA	Damora Therapeutics, Inc.	3,603,595	$93,333,110
8	OCUL	Ocular Therapeutix, Inc	10,346,926	$87,638,463

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$39,413,042	2,173,913	0.0%	Shares	Sole	2026-05-15
2025-12-31	$42,521,738	2,173,913	0.0%	Shares	Sole	2026-02-17
2025-09-30	$27,499,999	2,173,913	0.0%	Shares	Sole	2025-11-14
2025-06-30	$20,695,651	2,173,913	0.0%	Shares	Sole	2025-08-14
2025-03-31	$22,739,129	2,173,913	0.0%	Shares	Sole	2025-05-15
2024-12-31	$51,217,390	2,173,913	0.0%	Shares	Sole	2025-02-14
2024-09-30	$78,086,954	2,173,913	0.0%	Shares	Sole	2024-11-14
2024-06-30	$76,717,389	2,173,913	0.0%	Shares	Sole	2024-08-14
2024-03-31	$61,717,390	2,173,913	0.0%	Shares	Sole	2024-05-15
2023-12-31	$28,913,042	2,173,913	0.0%	Shares	Sole	2024-02-14
2023-09-30	$19,478,260	2,173,913	0.0%	Shares	Sole	2023-11-14
2023-06-30	$24,456,521	2,173,913	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.